Despite the US Congress’s lack of insight into Facebook’s operations, Mark Zuckerberg’s handling of the situation seems to have restored investor confidence in the company.
Johnson & Johnson marketing executive Debra Bass joins Nuvo
The potential is real, but companies and technology gurus often speak of machine learning as a catch-all solution. The hype may be slowing AI’s incremental growth in healthcare, experts say.
Ask someone who works in healthcare marketing, clinical research, or manufacturing to name the defining characteristics of their job. They’re likely to cite ethics right up there with improving human health. Either voluntarily or as a consequence of prior transgressions, industry has had to create ethics codes, such as informed consent for human trials,…
What is a digital medicine, exactly? Akili co-founder Adam Gazzaley explains
MM&M spoke with Gazzaley about what’s next for Akili, how he defines “digital medicine,” and where the field is currently positioned on the hype cycle.
SXSW: Tech empathy, data skepticism, and a Black Eyed Pea fuel health track’s surge